As of December 31, 2025, MEDICALE CORP. has 5.92M shares outstanding.
| Shares Outstanding | 5.92M |
As of December 31, 2025, MEDICALE CORP. maintains a current ratio of - -, meaning it holds the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -77.85, indicating conservative leverage, while an interest coverage ratio of -2.72 demonstrates limited ability to service its debt obligations.
| Debt / Equity | -77.85 |
| Debt / EBITDA | -5.23 |
| Interest Coverage | -2.72 |
These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -37,437.74, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -37,437.74 |
As of the close on October 7, 2026, MEDICALE CORP.'s stock has declined approximately 99.70% over the past 52 weeks. The 50-day moving average sits at 0.24, while the 200-day moving average is 0.25.
| 52-Week Price Change | -99.70% |
| 50-Day Moving Average | 0.24 |
| 200-Day Moving Average | 0.25 |
Over the twelve months ended December 31, 2025, MEDICALE CORP. generated - - in revenue and converted that into -29,763.00 in net income, yielding earnings per share of -0.01. EBITDA reached -21,642.00, while operating income came in at -21,642.00.
| Operating Income | -21,642.00 |
| Pretax Income | -29,763.00 |
| Net Income | -29,763.00 |
| EBITDA | -21,642.00 |
| EBIT | -21,642.00 |
| Earnings Per Share (EPS) | -0.01 |
As of December 31, 2025, MEDICALE CORP. holds - - in cash and equivalents against 113,174.00 in total debt, resulting in a net debt position of 113,174.00. Total book value stands at -145,376.00, with working capital of -32,202.00 providing operational flexibility.
| Total Debt | 113,174.00 |
| Net Debt | 113,174.00 |
| Equity (Book Value) | -145,376.00 |
| Book Value Per Share | -0.02 |
| Working Capital | -32,202.00 |
MEDICALE CORP. produced -19,748.00 in operating cash flow over the twelve months ended December 31, 2025.
| Operating Cash Flow | -19,748.00 |
| Free Cash Flow | -19,748.00 |